Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DE NOVO DONOR SPECIFIC ANTIBODIES AFTER KIDNEY TRANSPLANTATION: SINGLE-CENTER RETROSPECTIVE STUDY

NCT06425497 is registered in ClinicalTrials.gov with University of Rome Tor Vergata as lead sponsor.

NCT NCT06425497
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06425497 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DE NOVO DONOR SPECIFIC ANTIBODIES AFTER KIDNEY TRANSPLANTATION: SINGLE-CENTER RETROSPECTIVE STUDY
Lead sponsor
University of Rome Tor Vergata
Phase
Observational
Overall status
Completed
Start date
January 1, 2010
Completion date
May 6, 2024
Enrollment
600 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

immunosuppression, kidney transplant; complications